Novo Nordisk Aktie

107,94EUR -0,56EUR -0,52%
Novo Nordisk hier für 0 Euro handeln mit finanzen.net zero
WKN DE: A1XA8R / ISIN: DK0060534915
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>

Aktionärsstruktur

Inhaber in %
Freefloat 91,26

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2017 2018 2019 2020 2021
Personal am Ende des Jahres 42 076 43 202 43 258 45 323 47 792
Umsatz pro Mitarbeiter in Mio. EUR 2,65 2,59 2,82 2,80 2,95

Bilanz (in Mio. EUR) - Aktiva

2017 2018 2019 2020 2021
Summe Umlaufvermögen 60 080 59 067 62 456 65 809 85 595
Summe Anlagevermögen 51 509 52 354 62 076 73 681 97 391
Summe Aktiva 102 355 110 769 125 612 144 922 194 508

Bilanz (in Mio. EUR) - Passiva

2017 2018 2019 2020 2021
Gesamtverschuldung/ -verbindlichkeiten 1 694 515 4 483 10 356 26 645
Summe Fremdkapital 52 540 58 930 68 019 81 597 123 762
Summe Eigenkapital 49 815 51 839 57 593 63 325 70 746
Summe Passiva 102 355 110 769 125 612 144 922 194 508

Adresse

Novo Allé 1, 2880 Bagsværd
Internet http://www.novonordisk.com

Management

Andreas Fibig
Independent Director
Camilla Sylvest
EVP-Commercial Strategy & Corporate Affairs
Daniel Bohsen
Vice President & Head-Investor Relations
Doug Langa
EVP & Head-North America Operations
Elisabeth Dahl Christensen
Director
Helge Lund
Chairman
Henrik Ehlers Wulff
Executive VP & Head-Information Technology
Henrik Poulsen
Director
Irina Ivanischeva
Vice President & General Manager
Jane Buus Laursen
Corporate Vice President
Jeppe Fonager Christiansen
Vice Chairman
Jill Branca Priselac
Vice President-R&D, Business Development
John McDonald
Vice President-R&D, Business Development
Karsten Munk Knudsen
Chief Financial Officer & Executive Vice President
Kasim Kutay
Director
Lars Fruergaard Jørgensen
President & Chief Executive Officer
Laurence Debroux
Independent Director
Liselotte Hyveled
Director
Ludovic Helfgott
Executive Vice President & Head-Biopharm
Marcus Schindler
Chief Scientific Officer & Executive VP-Research
Martin Holst Lange
Executive Vice President & Head-Development
Martin W. MacKay
Independent Director
Maziar Mike Doustdar
Executive Vice President-International Operations
Mette Bøjer Jensen
Director
Monique Carter
Executive Vice President-People & Organization
Peter Jens Lindholm Kurtzhals
Senior Vice President-Global Research
Robin Evers
SVP-Medical Affairs, Regulatory & Safety
Sergey Manelis
Commercial Director
Stephen Gough
Global Chief Medical Officer
Sylvie Louise Grégoire
Independent Director
Thomas Rantzau
Director